About this Research Topic
Since 2019, COVID-19 has become the center of our personal and professional lives. Clinicians from all around the world had to recognize the novel form of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) related pulmonary and systemic diseases and its fast spreading rate.
Besides the outstanding effort towards the diagnosis and treatment of COVID-19, lung diseases other than COVID-19 continued to occur, develop, and spread. During the pandemic, clinicians will be expected to adapt by incorporating COVID-19 into their routine clinical practices. Clinicians must critically review patients throughout the diagnostic workup without neglecting pulmonary diseases besides COVID-19, particularly in the absence of a confirmatory result.
This Research Topic is dedicated to the diseases that were possibly neglected or received delayed diagnosis due to their mimicry of COVID-19 in clinical symptoms, laboratory and radiological findings, as a result of a partially or completely common pathophysiological background.
It is fundamental to develop strategies to adopt pandemic circumstances in order to reduce the likelihood of a misdiagnosis.
In the process of returning the life before pandemic, we shall not forget that COVID-19 will remain as a possible diagnosis for a respectable amount of time. However, we need to be open-minded for other prevalent or idiopathic diseases, which existed before the pandemic; as well as stay conscious about when to exclude COVID-19. Clinicians should not fall for the misleading perception that stems from fighting a pandemic. At the meantime, it is expected from physicians to distinguish the systemic effects of the SARS-CoV-2 infection from other pathologies that act as comorbidities, and to intervene timely to achieve a response to treatment.
The aim of this Research Topic is to shed light on possible misconceptions that occurred and continue to occur during the COVID-19 pandemic. This Topic wants to collect the current state of lung diseases other than COVID-19, and the impact of the COVID-19 pandemic on the chest diseases clinic. We welcome original research, brief reports, case reports, perspective articles, mini-reviews, and systematic reviews that assess the effects and outcomes of the COVID-19 pandemic on the area of lung diseases around the world.
Welcome topics include but are not limited to:
• Diseases that were potentially misdiagnosed and treated as COVID-19
• Strategies to differentiate COVID-19 from accompanying diseases
• The management of concurrent COVID-19 and co-morbid diseases
• Acute exacerbation of interstitial lung diseases that were misdiagnosed as COVID-19
• Management of delayed diagnosis of lung diseases
• Targeted management strategies to reduce the diagnostic errors during the pandemic
• Analysis of challenges during COVID-19 pandemic
• Implications of a current pandemic for public health agenda
For this Research Topic, Dr. Pinar Yildiz Gulhan has been recognized as a Research Topic Coordinator for their crucial role in assembling this project.
Besides the outstanding effort towards the diagnosis and treatment of COVID-19, lung diseases other than COVID-19 continued to occur, develop, and spread. During the pandemic, clinicians will be expected to adapt by incorporating COVID-19 into their routine clinical practices. Clinicians must critically review patients throughout the diagnostic workup without neglecting pulmonary diseases besides COVID-19, particularly in the absence of a confirmatory result.
This Research Topic is dedicated to the diseases that were possibly neglected or received delayed diagnosis due to their mimicry of COVID-19 in clinical symptoms, laboratory and radiological findings, as a result of a partially or completely common pathophysiological background.
It is fundamental to develop strategies to adopt pandemic circumstances in order to reduce the likelihood of a misdiagnosis.
In the process of returning the life before pandemic, we shall not forget that COVID-19 will remain as a possible diagnosis for a respectable amount of time. However, we need to be open-minded for other prevalent or idiopathic diseases, which existed before the pandemic; as well as stay conscious about when to exclude COVID-19. Clinicians should not fall for the misleading perception that stems from fighting a pandemic. At the meantime, it is expected from physicians to distinguish the systemic effects of the SARS-CoV-2 infection from other pathologies that act as comorbidities, and to intervene timely to achieve a response to treatment.
The aim of this Research Topic is to shed light on possible misconceptions that occurred and continue to occur during the COVID-19 pandemic. This Topic wants to collect the current state of lung diseases other than COVID-19, and the impact of the COVID-19 pandemic on the chest diseases clinic. We welcome original research, brief reports, case reports, perspective articles, mini-reviews, and systematic reviews that assess the effects and outcomes of the COVID-19 pandemic on the area of lung diseases around the world.
Welcome topics include but are not limited to:
• Diseases that were potentially misdiagnosed and treated as COVID-19
• Strategies to differentiate COVID-19 from accompanying diseases
• The management of concurrent COVID-19 and co-morbid diseases
• Acute exacerbation of interstitial lung diseases that were misdiagnosed as COVID-19
• Management of delayed diagnosis of lung diseases
• Targeted management strategies to reduce the diagnostic errors during the pandemic
• Analysis of challenges during COVID-19 pandemic
• Implications of a current pandemic for public health agenda
For this Research Topic, Dr. Pinar Yildiz Gulhan has been recognized as a Research Topic Coordinator for their crucial role in assembling this project.
Keywords: Pulmonary Medicine, Lung Diseases, COVID-19, Diagnosis, Comorbid Diseases, Therapy, Medicine and Public Health
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
